A Study of MGC026 in Participants With Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Advanced Solid Tumor · Advanced Cancer · Metastatic Cancer · Squamous Cell Carcinoma of Head and Neck · Non Small Cell Lung Cancer · Small-cell Lung Cancer · Bladder Cancer · Sarcoma · Endometrial Cancer · Melanoma · Castration Resistant Prostatic Cancer · Cervical Cancer · Colorectal Cancer · Gastric Cancer · Gastro-esophageal Cancer · Pancreas Cancer · Clear Cell Renal Cell Carcinoma · Hepatocellular Carcinoma · Platinum-resistant Ovarian Cancer · Breast Cancer · Ovarian Cancer · Esophageal Squamous Cell Cancer (SCC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • The Angeles Clinic and Research Institute, Los Angeles, California, United States

  • START Midwest, Grand Rapids, Michigan, United States

  • START-New York Long Island, Lake Success, New York, United States

  • Providence Cancer Institute, Portland, Oregon, United States

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • University of Texas Health Science Center at Houston, Houston, Texas, United States

  • START Mountain Region, West Valley City, Utah, United States

  • ICON Cancer Centre Wesley, Auchenflower, Queensland, Australia

  • ICON Cancer Centre Kurralta Park, Kurralta Park, South Australia, Australia

  • Austin Health- Olivia Newton John Cancer Center, Heidelberg, Victoria, Australia

  • Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

מובילי המחקר
  • Denise Casey, MD

    Study Director

    MacroGenics